SCHEMBL21780679

SCHEMBL21780679

Cc1cnccc1CS(C)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC1 P19801 3/20 0.38
AOC3 Q16853 3/20 0.38
OPRM1 P35372 1/20 0.37
OPRL1 P41146 1/20 0.37
PTGS1 P23219 4/20 0.36
PTGS2 P35354 4/20 0.36
SIRT3 Q9NTG7 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HTR6 P50406 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP2E1 P05181 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21768438 0.79 CA2 (0.39) AOC1AOC3OPRM1OPRL1PTGS1
SCHEMBL214076 0.77
SCHEMBL19105567 0.77 AOC1 (0.36) AOC1AOC3OPRM1OPRL1PTGS1
SCHEMBL1271423 0.77 SLC22A12 (0.41) PTGS1PTGS2CYP17A1
SCHEMBL15810238 0.75 SLC22A12 (0.43) AOC1AOC3OPRM1OPRL1PTGS1
SCHEMBL19145209 0.74 ALDH1A1 (0.35) AOC1AOC3OPRM1OPRL1PTGS1
SCHEMBL1272238 0.74 CYP17A1 (0.45) OPRM1OPRL1PTGS2CYP17A1CYP2E1
Iodomethane SCHEMBL11651462 0.74 CYP2E1 (0.43) AOC1AOC3SIRT3TDP1CYP2E1
SCHEMBL1273174 0.73 PDE3B (0.41) PTGS1PTGS2CYP17A1CYP2D6CYP2A6
SCHEMBL1272715 0.73 PTGS2 (0.50) PTGS1PTGS2CYP2E1CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303573-A1 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Grünenthal GmbH (DE) 2023-09-28 US disclosed
US-20230303573-A1 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Grünenthal GmbH (DE) 2023-09-28 US disclosed
EP-3722284-A1 3-((HETERO-)ARYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES Grünenthal GmbH (DE) 2020-10-14 EP disclosed
EP-3402781-B1 3-((HETERO-)ARYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES GRUENENTHAL GMBH (DE) 2020-03-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303573-A1 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives OPRK1, OPRD1, OPRL1 AOC1 1308/4885AOC3 1035/4885OPRM1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.